Better Health for All

Haleon empowered over 50 million people in 2024 to be more included in opportunities for better everyday health.

The company aims to increase people's understanding and confidence in managing their own health, with 8 out of 10 individuals recognizing self-care responsibility but only 2 out of 10 feeling confident. Haleon and Microsoft collaborated to improve accessibility for visually impaired and low-literacy consumers, narrating product labels for over 1500 products in the UK and US. An independent study found 93% of visually impaired respondents felt health products were not accessible enough. Haleon divested its non-US Nicotine Replacement Therapy business. The company made a 3-year commitment in 2021 to support pharmacists, providing tools and resources for workload efficiency and mental resilience. Haleon partnered with Direct Relief in a multi-year commitment to expand access to everyday health for underserved communities, donating over 80,000 essential health items and supporting crisis responses in Ukraine, Turkey, and Syria. Haleon invested £130 million in a Global Oral Health Innovation Centre, which represents 1.16% of its £11.2 billion 2024 revenue. The company's reporting criteria are publicly available on its website.

Fair Money & Economic Opportunity

Haleon PLC is a consumer healthcare company, not a financial institution.

The company does not offer lending, deposit, or other financial services to consumers. Therefore, all KPIs related to financial services, such as underserved client share in finance, pricing fairness (APRs/fees), exploitative fee exposure, financial inclusion initiatives (loan/insurance book), financial data accessibility, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion for banking, and product simplicity for financial products, are not applicable to its core business operations. While Haleon addresses underserved demographics and affordability in healthcare, this does not translate to the financial services context of this value.

Fair Pay & Worker Respect

The CEO to median employee pay ratio was 82:1 in 2024, following ratios of 51:1 in 2023 and 32:1 in 2022.

In 2022, the median hourly pay gap for Haleon UK was 7.7%, meaning women earned 92.3% of men's median hourly pay. The employee engagement score was 81% in 2024, an improvement from 78% in 2023. The company has a clean record with no specific regulatory actions, violations, fines, or compliance issues mentioned in the 2024 Responsible Business Report.

Fair Trade & Ethical Sourcing

In 2023, 12% of Haleon's US third-party discretionary spend was directed to diverse-owned businesses.

The company also launched supplier diversity programs in the UK, Canada, Australia, and South Africa.

Honest & Fair Business

Haleon incurred $5,472,351 in ethics-related regulatory fines in 2025 for anti-competitive practices in Belgium.

The company restated financial data for 2023 and 2024 due to a change in reporting categories. Haleon has a 'Speak Up' program with channels (telephone, web portal, email, mail) for reporting concerns, which are managed independently and available globally in multiple languages, alongside an EU Whistleblowing Policy. The company has an Anti-Bribery and Corruption (ABAC) Policy with zero tolerance for corruption, requiring mandatory annual ABAC training and pre-approval for payments above £20 to government officials. KPMG LLP provides independent limited assurance over selected responsible business data using ISAE(UK)3000 and ISAE 3410 standards.

Kind to Animals

Haleon's animal testing policy states that animals are only used in research when alternative methods are unavailable and there are specific scientific, legal, or regulatory requirements, with a commitment to the 3Rs (Replace, Reduce, Refine).

This policy includes a rigorous assessment and approval process, overseen by experienced scientists and external veterinary expertise, and requires approval from the Chief Medical Officer. The company has adopted in vitro methods for eye, oral mucosa, and skin irritation/sensitization, and pioneered alternative technology for fluoride availability in toothpaste. Haleon has contributed £1.1 million over the past 10 years to animal alternatives. The company is involved in initiatives like the Cosmetics Europe LRSS and AAT programs and has committed to join the ICCS. Haleon works with policymakers and external organizations to shape public policy, including developing proactive proposals.

No War, No Weapons

No specific, quantifiable evidence was found in the provided articles to assess Haleon PLC against the 'No War, No Weapons' ethical value. The articles primarily detail the company's general human rights policies

, supplier codes of conduct , and conflict minerals disclosure processes , but do not provide performance metrics or specific data points related to arms contracts, dual-use technologies, sales to sanctioned regimes, peacebuilding investments, or the percentage of its supply chain certified free from conflict minerals.

Planet-Friendly Business

In 2023, the company's total Scope 1, 2, and 3 greenhouse gas emissions were 2.403 million tCO₂e.

While Scope 1 and 2 emissions decreased by 48% versus a 2020 baseline, Scope 3 emissions increased by 4% versus a 2022 baseline. The company has SBTi-validated near-term targets to reduce absolute Scope 1 and 2 GHG emissions by 95% by 2030 from a 2020 base year, and Scope 3 GHG emissions by 42% versus a 2022 baseline within the same timeframe. The net-zero emissions target year is 2040. The company achieved 100% renewable electricity consumption in 2022 and 2023. Water withdrawal in 2023 was 2.18 million m³, with 4 out of 24 sites located in water-stressed basins. The company targets water neutrality in water-stressed basins by 2030 and Alliance for Water Stewardship (AWS) certification for all manufacturing sites by 2025; 12 sites are already AWS certified, with 7 more recommended. There were no significant environmental fines or penalties reported for 2020-2023. The company conducted TCFD analysis in 2022 and performs climate-related scenario analysis for 1.5°C, 2°C, and 4°C pathways. It has assessed 11 key products for lifecycle environmental impacts. The company aims to reduce virgin plastic use by 10% by 2025 and 33% by 2030 versus a 2022 baseline, and has achieved a reduction in carbon footprint for Sensodyne toothpaste. The company has a commitment to sustainably sourced materials and has an afforestation project covering 50,000 hectares.

Respect for Cultures & Communities

Haleon provides 'Speak Up' channels globally via telephone, web portal, email, or mail, managed independently and available in multiple languages, indicating over 90% coverage for grievance mechanisms.

The company's Code of Conduct is available in 16 languages, and 'Speak Up' channels are globally available in multiple languages, demonstrating strong local language support. Concerns raised through these channels are reviewed in detail by colleagues in Ethics & Compliance, Legal, and/or HR, with formal investigations possible, indicating a proactive prevention and rapid response framework for cultural incidents.

Safe & Smart Tech

Haleon has established Responsible AI Principles and a Responsible AI Policy to mitigate AI risks, which aligns with industry-standard AI ethics considerations.

The company provides mandatory Code of Conduct training, including data security, indicating a standard approach to employee security awareness. Haleon also has vulnerability management, monitoring, and alerting processes in place. Furthermore, the company states it complies with relevant privacy regulations, including GDPR and SOX, reflecting a basic level of regulatory compliance.

Zero Waste & Sustainable Products

Haleon reports that 70% of its packaging is sustainable.

However, the company experienced a 3% increase in single-use plastic from its 2022 baseline. Haleon has set company-wide waste reduction targets, aiming to reduce virgin petroleum-based plastic by 10% by 2025 and 33% by 2030 from a 2020 baseline, and to achieve TRUE Certification at all manufacturing sites by 2030.